H. Michael Shepard

#	Item
1	ESA Patentverwertungsagentur Sachsen-Anhalt GmbH Technology Offer Novel enzyme inhibitors for the treatment of aggressive forms of breast cancer Add to Reading List Source URL: www.esa-pva.de Language: English - Date: 2014-09-18 05:29:30 HER2/neu Breast cancer H. Michael Shepard Trastuzumab Medicine Biology Ribbon symbolism
2	Contact: Dale R. Heffler[removed]removed] For Immediate Release October 28, 2013 Add to Reading List Source URL: www.foundationventure.com Language: English - Date: 2013-10-29 13:28:04 Tumor markers Carcinogenesis Cancer Occupational safety and health Pathology BRCA2 Breast cancer Management of cancer H. Michael Shepard Medicine Oncology Tumor suppressor genes
3	HER2-targeted T-cell Therapies Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 13:16:49 Biology Trastuzumab HER2/neu Ribbon symbolism Breast cancer Protein kinase inhibitor Osteosarcoma H. Michael Shepard Medicine Oncology Tyrosine kinase receptors
4	Zyngenia Publishes New Data Demonstrating Preclinical Efficacy of its Multi-Specific Antibody Therapeutics in Treating Cancer -- Article in mAbs Shows that Therapeutics Inhibit Tumor Cell Proliferation by Simultaneously Add to Reading List Source URL: www.zyngenia.com Language: English - Date: 2013-06-10 17:56:00 Monoclonal antibodies Monoclonal antibody therapy Autoimmunity Biologic Trubion H. Michael Shepard Immunology Medicine Biology